Response Adapted Therapy
Showing 1 - 25 of >10,000
Follicular Lymphoma, Non-Hodgkin's Lymphoma, NHL Trial run by the National Cancer Institute (NCI) (Rituximab, Copanlisib)
Recruiting
- Follicular Lymphoma
- +2 more
- Rituximab
- Copanlisib
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Lymphoma Trial (Ultra Low Dose 4 Gy Radiation)
Not yet recruiting
- Lymphoma
- Ultra Low Dose 4 Gy Radiation
- (no location specified)
Jun 30, 2023
Diffuse Large B Cell Lymphoma (DLBCL) Trial in Toronto (glofitamab)
Not yet recruiting
- Diffuse Large B Cell Lymphoma (DLBCL)
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Sep 18, 2023
Gastroesophageal Adenocarcinoma Trial in Orange (device, combination product, drug)
Not yet recruiting
- Gastroesophageal Adenocarcinoma
- ctDNA Blood Test
- +8 more
-
Orange, CaliforniaChao Family Comprehensive Cancer Center, University
Feb 8, 2023
Nasopharyngeal Cancer Trial in Shanghai (Toripalimab, Induction chemo and concurrent chemoradiation)
Recruiting
- Nasopharyngeal Cancer
- Toripalimab
- Induction chemotherapy and concurrent chemoradiation
-
Shanghai, Shanghai, ChinaFudan Universtiy Shanghai Cancer Centre
Nov 25, 2022
Breast Cancer Trial in Shanghai (axillary surgery de-escalation after NAT)
Recruiting
- Breast Cancer
- axillary surgery de-escalation after NAT
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center Shanghai, China, 200032
Jun 13, 2023
Multiple Myeloma Trial in Tampa (Lenalidomide, Prednisone, Dexamethasone)
Completed
- Multiple Myeloma
- Lenalidomide
- +2 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Oct 8, 2021
Hepatoblastoma Trial in Shanghai (Sodium Thiosulfate Injection, Primary surgery resection, mono CDDP-Group A2)
Recruiting
- Hepatoblastoma
- Sodium Thiosulfate Injection
- +10 more
-
Shanghai, Shanghai, ChinaShanghai Children's Medical Center
Jul 23, 2022
Hodgkin Lymphoma Trial in Copenhagen (ABVD + FDG-PET/CT Scan treatment adaptation, BEACOPPesc)
Withdrawn
- Hodgkin Lymphoma
- ABVD + FDG-PET/CT Scan treatment adaptation
- BEACOPPesc
-
Copenhagen, DenmarkRigshospitalet
Feb 11, 2021
Non Small Cell Lung Cancer Metastatic Trial in Morgantown (Radiation, Immuno-Therapeutic Agent)
Active, not recruiting
- Non Small Cell Lung Cancer Metastatic
- Radiation
- Immuno-Therapeutic Agent
-
Morgantown, West VirginiaWVU Cancer Institute - Mary Babb Randolph Cancer Center
Apr 25, 2022
Advanced Hodgkin Lymphoma Trial in Worldwide (Brentuximab Vedotin, Adriamycin, Vinblastine)
Active, not recruiting
- Advanced Hodgkin Lymphoma
- Brentuximab Vedotin
- +6 more
-
Antwerp, Belgium
- +18 more
May 4, 2022
Lymphoma Trial in Southampton (bleomycin sulfate, filgrastim, pegfilgrastim)
Active, not recruiting
- Lymphoma
- bleomycin sulfate
- +10 more
-
Southampton, England, United KingdomSouthampton General Hospital
Apr 27, 2021
Chronic Lymphocytic Leukemia Trial (Evaluation of response to treatment with response-tailored Ibrutinib in patients with
Not yet recruiting
- Chronic Lymphocytic Leukemia
- Evaluation of response to treatment with response-tailored Ibrutinib in patients with chronic lymphocytic leukemia
- (no location specified)
Dec 27, 2022
Peripheral Arterial Disease Trial in Worldwide (Duplex Ultrasound (DUS), IVUS with Intraarterial pressure measurement (IAP) if
Active, not recruiting
- Peripheral Arterial Disease
- Duplex Ultrasound (DUS)
- IVUS with Intraarterial pressure measurement (IAP) if needed
-
Perth, Western Australia, Australia
- +14 more
Aug 24, 2022
Hodgkin Lymphoma Trial (Tislelizumab, AVD, Radiotherapy)
Not yet recruiting
- Hodgkin Lymphoma
- Tislelizumab, AVD, Radiotherapy
- (no location specified)
Nov 15, 2022
Multiple Myeloma Trial (Continued treatment adapted to the response)
Completed
- Multiple Myeloma
- Continued treatment adapted to the response
- (no location specified)
Jan 14, 2023
Self Harm, Borderline Personality Disorder Trial in Norway (Dialectical Behaviour Therapy adapted for adolescents (DBT-A),
Recruiting
- Self Harm
- Borderline Personality Disorder
- Dialectical Behaviour Therapy adapted for adolescents (DBT-A)
- Dialectical Behaviour Therapy - Standard version (DBT)
-
Moss, Norway
- +4 more
Sep 12, 2021
Hemophagocytic Lymphohistiocytosis Trial in United States (Ruxolitinib, Dexamethasone, Etoposide)
Recruiting
- Hemophagocytic Lymphohistiocytosis
- Ruxolitinib
- +2 more
-
Phoenix, Arizona
- +9 more
Jan 9, 2023
Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in United States (drug, other, biological)
Active, not recruiting
- Recurrent Hodgkin Lymphoma
- Refractory Hodgkin Lymphoma
- Carboplatin
- +4 more
-
Duarte, California
- +3 more
Oct 24, 2022
Internet Gaming Disorder Trial in Islamabad (Indigenously Adapted Cognitive Behavioral Therapy)
Recruiting
- Internet Gaming Disorder
- Indigenously Adapted Cognitive Behavioral Therapy
-
Islamabad, Federal Capital Area, PakistanBahria University
Jun 23, 2023
Postnatal Depression Trial (Culturally Adapted Manual Assisted Therapy (CMAP-SI))
Not yet recruiting
- Postnatal Depression
- Culturally Adapted Manual Assisted Therapy (CMAP-SI)
- (no location specified)
May 15, 2023
Nervous System Diseases, Oculomotor; Disorder, Physical Dependence Trial in Málaga (Oculomotor therapy, Adapted yoga)
Not yet recruiting
- Nervous System Diseases
- +4 more
- Oculomotor therapy
- Adapted yoga
-
Málaga, SpainUniversidad de Málaga
Jan 23, 2023
Suicidal Ideation Trial in Rawalpindi (ECMAP)
Not yet recruiting
- Suicidal Ideation
- ECMAP
-
Rawalpindi, Punjab, PakistanBenazir Bhutto Hospital
Aug 25, 2023
Acquired Brain Injury Trial (Exercise therapy and adapted physical activity-based program)
Not yet recruiting
- Acquired Brain Injury
- Exercise therapy and adapted physical activity-based program
-
Madrid, SpainSecond Part Foundation
Dec 13, 2022